X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. GSK PHARMA FDC LTD./
GSK PHARMA
 
P/E (TTM) x 28.9 62.9 46.0% View Chart
P/BV x 6.0 10.1 59.7% View Chart
Dividend Yield % 0.8 1.3 62.6%  

Financials

 FDC LTD.   GSK PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
GSK PHARMA
Mar-17
FDC LTD./
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1443,838 3.7%   
Low Rs792,637 3.0%   
Sales per share (Unadj.) Rs47.6354.2 13.4%  
Earnings per share (Unadj.) Rs7.639.8 19.1%  
Cash flow per share (Unadj.) Rs9.042.9 21.0%  
Dividends per share (Unadj.) Rs2.2530.00 7.5%  
Dividend yield (eoy) %2.00.9 218.3%  
Book value per share (Unadj.) Rs47.5236.9 20.1%  
Shares outstanding (eoy) m177.8384.70 210.0%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.39.1 25.6%   
Avg P/E ratio x14.681.4 18.0%  
P/CF ratio (eoy) x12.375.5 16.3%  
Price / Book Value ratio x2.313.7 17.1%  
Dividend payout %29.675.4 39.2%   
Avg Mkt Cap Rs m19,784274,216 7.2%   
No. of employees `000NA4.7 0.0%   
Total wages/salary Rs m1,2214,830 25.3%   
Avg. sales/employee Rs ThNM6,387.0-  
Avg. wages/employee Rs ThNM1,028.3-  
Avg. net profit/employee Rs ThNM717.1-  
INCOME DATA
Net Sales Rs m8,45930,000 28.2%  
Other income Rs m394728 54.0%   
Total revenues Rs m8,85230,728 28.8%   
Gross profit Rs m2,0704,190 49.4%  
Depreciation Rs m249263 94.7%   
Interest Rs m310-   
Profit before tax Rs m2,1844,655 46.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m0457 0.0%   
Tax Rs m6061,744 34.7%   
Profit after tax Rs m1,3533,368 40.2%  
Gross profit margin %24.514.0 175.2%  
Effective tax rate %27.737.5 74.0%   
Net profit margin %16.011.2 142.5%  
BALANCE SHEET DATA
Current assets Rs m4,35516,742 26.0%   
Current liabilities Rs m1,7927,202 24.9%   
Net working cap to sales %30.331.8 95.3%  
Current ratio x2.42.3 104.6%  
Inventory Days Days4452 85.8%  
Debtors Days Days2521 118.7%  
Net fixed assets Rs m3,0258,635 35.0%   
Share capital Rs m179847 21.1%   
"Free" reserves Rs m8,24319,222 42.9%   
Net worth Rs m8,45320,069 42.1%   
Long term debt Rs m1110 107.0%   
Total assets Rs m10,55730,038 35.1%  
Interest coverage x71.4NM-  
Debt to equity ratio x00 254.0%  
Sales to assets ratio x0.81.0 80.2%   
Return on assets %13.111.2 116.9%  
Return on equity %16.016.8 95.4%  
Return on capital %23.525.5 92.3%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,146528 217.1%   
Fx outflow Rs m3557,193 4.9%   
Net fx Rs m791-6,665 -11.9%   
CASH FLOW
From Operations Rs m1,4852,360 62.9%  
From Investments Rs m-6203,008 -20.6%  
From Financial Activity Rs m-753-5,108 14.7%  
Net Cashflow Rs m113260 43.3%  

Share Holding

Indian Promoters % 68.9 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 4.7 10.2 46.1%  
FIIs % 7.5 23.8 31.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 15.4 123.4%  
Shareholders   23,730 102,036 23.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  NOVARTIS  DR. DATSONS LABS  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Metal Stocks Top Losers(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading marginally above the dotted line.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Feb 21, 2018 02:51 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - AJANTA PHARMA COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS